Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794478 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 482
- Enrollment target
NCT04794478: Completed NA study, sponsored by DexCom.
NCT04794478 is a NA study that has completed, run by DexCom. The registered enrollment target is 482 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04794478, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 482 participants
- Enrollment target
Study Summary
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
Primary Outcome
The Dexcom Continuous Glucose Monitoring (CGM) System performance will be assessed compared to the Yellow Springs Instrument (YSI) comparator venous plasma measurements
Interventions
- DEVICE Dexcom Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT04794478 record still lists
NCT04794478 is an interventional study that assigns participants to a tested intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which Dexcom Continuous Glucose Monitoring System is the first listed.
NCT04794478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04794478 about?
NCT04794478 is a clinical study titled "Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System". Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
What is the current status of trial NCT04794478?
This trial is currently completed. It is a NA study. The enrollment target is 482 participants. The study started on 2021-02-19. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT04794478?
The interventions under investigation include: Dexcom Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT04794478?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04794478's enrollment target sits among peer trials
482 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI